Literature DB >> 6640542

"COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude mice.

P A Meitner, S M Kajiji, N LaPosta-Frazier, H A Bogaars, G A Jolly, D L Dexter, P Calabresi, M D Turner.   

Abstract

The human pancreatic cancer cell line COLO 357 has been xenografted s.c. in athymic Swiss mice. The xenografts grew well to form typical adenosquamous carcinomas. The cells were placed in a perfused artificial capillary system where they formed a solid tumor mass which survived for 7 weeks. In this system, the cells consumed glucose and released enzymes and carcinoembryonic antigen into the extracapillary space.

Entities:  

Mesh:

Year:  1983        PMID: 6640542

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2).

Authors:  T Iwamura; T Katsuki
Journal:  Gastroenterol Jpn       Date:  1987-10

2.  Establishment and characterization of a new transplantable pancreatic cancer xenograft (PZX-5) in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; F Timár; I Babó
Journal:  Int J Pancreatol       Date:  1998-02

Review 3.  Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Authors:  Erkut Borazanci; Sherri Z Millis; Ron Korn; Haiyong Han; Clifford J Whatcott; Zoran Gatalica; Michael T Barrett; Derek Cridebring; Daniel D Von Hoff
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

4.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

Authors:  Bence Sipos; Simone Möser; Holger Kalthoff; Virag Török; Matthias Löhr; Günter Klöppel
Journal:  Virchows Arch       Date:  2003-04-12       Impact factor: 4.064

5.  Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers.

Authors:  Joel D Maust; Christy L Frankowski-McGregor; Armand Bankhead; Diane M Simeone; Judith S Sebolt-Leopold
Journal:  Mol Cancer Ther       Date:  2018-09-25       Impact factor: 6.261

6.  Tissue factor activity on microvesicles from cancer patients.

Authors:  Fanny Ender; Annika Freund; Tabea Quecke; Corinna Steidel; Piet Zamzow; Nikolas von Bubnoff; Frank Gieseler
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-16       Impact factor: 4.553

7.  Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis.

Authors:  Corinna Steidel; Fanny Ender; Achim Rody; Nikolas von Bubnoff; Frank Gieseler
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

8.  Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β.

Authors:  Jyoti B Kaushal; Rakesh Bhatia; Ranjana K Kanchan; Pratima Raut; Surya Mallapragada; Quan P Ly; Surinder K Batra; Satyanarayana Rachagani
Journal:  Cancers (Basel)       Date:  2021-06-22       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.